发明名称 |
2-substituted-1,3-thiazole compounds |
摘要 |
The present invention relates to new compounds of formula I, Wherein Y is NR<SUP>4</SUP>CONR<SUP>4</SUP>, NR<SUP>4</SUP>CO, or NR<SUP>4</SUP>; R<SUP>1 </SUP>is nitro or COR<SUP>5</SUP>; R<SUP>2 </SUP>is hydrogen or NH<SUB>2</SUB>; R<SUP>3 </SUP>is C<SUB>1-6</SUB>alkyl or C<SUB>0-6</SUB>alkylaryl wherein C<SUB>0-6</SUB>alkylaryl may be substituted by A; R<SUP>4 </SUP>is hydrogen; R<SUP>5 </SUP>is C<SUB>1-6</SUB>alkyl; A is independently selected from halo, OR<SUP>6 </SUP>and C<SUB>1-6</SUB>alkyl; R<SUP>6 </SUP>is C<SUB>1-6</SUB>alkyl; provided that the compound is not N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea as a free base or a salt thereof as well as a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.
|
申请公布号 |
US2005119321(A1) |
申请公布日期 |
2005.06.02 |
申请号 |
US20040510846 |
申请日期 |
2004.10.12 |
申请人 |
BERG STEFAN;HELLBERG SVEN |
发明人 |
BERG STEFAN;HELLBERG SVEN |
分类号 |
C07D277/20;A61K31/426;A61P3/10;A61P5/48;A61P15/00;A61P15/18;A61P17/14;A61P21/04;A61P25/00;A61P25/14;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D277/42;C07D277/46;C07D277/48;C07D277/58;(IPC1-7):C07D277/38 |
主分类号 |
C07D277/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|